Credent Connect N Care Ltd (CREDENT) is currently trading at 401.70 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Credent Connect N Care Limited provides integrated healthcare logistics, phlebotomy, sample collection, workforce solutions, wellness programs, and technology-enabled operational support to diagnostic laboratories, hospitals, healthcare enterprises, and corporates across India. The company has evolved from a cold-chain logistics operator founded in 2015 into a broader healthcare pre-analytics platform, combining collection, transportation, tracking, workforce management, IT support, and corporate wellness services under an integrated operating model. H1 FY27 revenue increased 53% year-on-year to INR138 crore, while EBITDA rose 53% to INR18 crore and reported PAT grew 95% to INR14.65 crore. Excluding a INR1.78 crore one-time tax credit, PAT still increased 71% to INR12.87 crore. Healthcare services represented 45.84% of H1 revenue and are described by management as more profitable than logistics, while logistics contributed 24.81% and IT and operational supply-chain services contributed 29.35%. This mix creates potential for margin improvement as higher-value services scale. Management is targeting approximately INR320 crore revenue in FY27 and around INR1,000 crore by FY30, alongside 15%–16% EBITDA margins and approximately 10% PAT margins. These targets are substantial and depend on execution, customer additions, working-capital discipline, and successful integration of acquired capabilities.

Over the past 52 weeks, Credent Connect N Care Ltd has traded between a low of ₹292.00 and a high of ₹420.35. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Credent Connect N Care Ltd has a market capitalization of approximately 732.01. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Credent Connect N Care Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 28.72 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 732.01 Cr, Credent Connect N Care Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Credent Connect N Care Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Credent Connect N Care Ltd is 28.72. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Credent is targeting revenue of more than Rs 320 crore in FY27. It reported Rs 138 crore in H1 FY27, and management said H2 normally contributes 55% to 60% of annual revenue because of seasonality.

No. Credent said it will not expand overseas during the current financial year because management cited war conditions in the Middle East. The UAE remains a target market, but no launch date or UAE contract was disclosed.

Credent is limiting credit for new clients to a maximum of 30 days to improve collections. Management said earlier terms were 45 to 60 days and debtor ageing is about 60 days. Its stated target is to reduce debtor ageing to below 45 days.

Credent management is targeting an EBITDA margin of around 15% to 16% over three years. It reported a 13% EBITDA margin in H1 FY27, unchanged from H1 FY26. Management said progress depends on operational execution and working-capital improvement.